Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.02 – $0.09
6% from low
Exchange
OTC Link
OS
Borrow rate
1.17%
Moderate
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.1M | $28.5M | $52.4M | $65.4M | $87.7M | $97.3M | $103.6M | $86.7M |
| Cost of revenue | $5.2M | $10.5M | $22.5M | $29.6M | $50.7M | $49.8M | $49.0M | $58.6M |
| Gross profit | $2.9M | $18.1M | $29.9M | $35.8M | $37.0M | $47.5M | $54.6M | $28.1M |
| Gross margin | 35.6% | 63.3% | 57.0% | 54.7% | 42.2% | 48.9% | 52.7% | 32.4% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$20.3M | −$30.9M | −$8.4M | −$3.1M | $3.0M | $9.3M | $6.5M | −$15.2M |
| EBITDA | −$18.5M | −$25.4M | −$8.2M | $6.7M | $2.9M | $23.9M | $1.3M | −$26.3M |
| Net income | −$327.0K | −$53.2M | −$36.7M | −$19.0M | −$37.1M | −$22.8M | −$40.4M | −$72.5M |
| Net margin | -4.1% | -186.7% | -70.1% | -29.0% | -42.4% | -23.4% | -39.0% | -83.6% |
| EPS (diluted) | -0.00 | -0.29 | -0.18 | -0.08 | -0.15 | -0.08 | -0.13 | -0.10 |
Annual figures · source: Financial Modeling Prep
FLUENT CORP
No one on the platform currently holds CNTMF.
No tracked institution reports a position in CNTMF as of their last filing.
No one on the platform has traded CNTMF yet.
| $33M |
| — |
| HSTIHigh Sierra Technologies, Inc. | $1.40 | +0.00% | $29M | — |
| ISCNFIsracann Biosciences Inc. | $0.00 | +0.00% | $1760 | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 0.1× sales vs its 0.5× historical median P/S.
Fair value ≈ $0.18 · price $0.02 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$CNTMF worst investment ever. The original owners had no idea about how to run a company, wasted money and smoked it all. Misled all investors
View on StockTwits ↗$CNTMF ClassAction Lawsuit currently being filed against CNTMF. The deal with Vireo is not going to go through. They are currenlty looking for lead plantiffs. the Law Firm will be contacting stock holder shortly. Please note: to build a strong case against a cannabis/marijuana company, thorough preparation is essential. Start by documenting the issue or harm caused by the company, ensuring you have a clear and comprehensive record. Gather any evidence supporting your claim, such as contracts, correspondence, receipts and emails. It's highly advisable to consult with an attorney specialized in cannabis/marijuana law who can guide you through the process and provide valuable insights based on their expertise.
View on StockTwits ↗$VREOF $CNTMF Vireo Growth acquiring FLUENT in all-stock merger. Combined entity will have ~74 Florida dispensaries + 144K sq ft cultivation. FLUENT did $71.5M revenue in FL (2025). Debt restructure includes $30M conversion to equity. 38.3% shareholder support locked. Close Q4 2026. #Cannabis https://prismmarketview.com/vireo-growth-expands-florida-cannabis-footprint-with-fluent-acquisition/
View on StockTwits ↗$CNTMF I’m thinking with recent news and changes in the industry these guys have become a target for purchase.
View on StockTwits ↗$CNTMF thats one of a few that will belly up before the sector pump. Sorry for your losses folks.
View on StockTwits ↗$CNTMF think I’m going to start adding weekly here. They will be taken out after rescheduling happens. JMO
View on StockTwits ↗$CNTMF I think these dudes will get taken private and/or bought out for licensing, footprint and grow ops in 2026.
View on StockTwits ↗(OTCQB: $CNTMF) @fluentcannabis reported Q3 revenue of $26M with margins under pressure, but says premium indoor capacity is now coming online in FL & NY. The Rosa facility nearly doubled premium flower output, and Connected/Alien Labs SKUs launch in NY next month. Management expects margin recovery in Q4 as yields improve and the federal hemp crackdown reshapes competition in FL & TX. https://prismmarketview.com/fluent-reports-third-quarter-2025-results-as-company-works-to-restore-margins-and-scale-premium-indoor-production/
View on StockTwits ↗(OTCQB: $CNTMF) Fluent Corp. completed its first harvest at the new Rosa indoor cultivation facility in Florida, producing 400 pounds of primarily premium cannabis flower and expanding its indoor canopy by 25%. This milestone supports growing demand for premium products in Florida’s cannabis market, enhances operational efficiency, and strengthens Fluent's growth strategy in a rapidly expanding state market. https://prismmarketview.com/fluent-completes-first-harvests-at-new-rosa-facility-strengthening-florida-cannabis-growth-strategy/
View on StockTwits ↗(OTCQB: $CNTMF) #fluentcannabis Corp. rebranded its Manhattan and White Plains dispensaries under the FLUENT name, unifying all three New York retail locations following its RIV Capital acquisition. The move integrates stores into its digital platform for online ordering and expands access to brands like MOODS, Knack, and Wandr. A new Buffalo cultivation facility’s first harvest is expected in Q4. https://prismmarketview.com/fluent-unifies-new-york-retail-network-with-dispensary-rebrands/
View on StockTwits ↗$CNTMF quick napkin math says 1-2 mln shares left to unload. Perfect timing.
View on StockTwits ↗$CNTMF New CEO just took a private placement deal for himself. Talk about making a good first impression.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.